COVID Resurgence: Winter Preparedness and Protection Strategies
Experts outline key measures to navigate the seasonal COVID wave and emerging variants.
1Regional spread patterns
Wastewater data shows SARS-CoV-2 levels rising since July, with sharpest increases in western and southern states. The XFG variant now accounts for nearly half of cases, first emerging in early 2025. Unlike previous years, hospitalizations haven't followed the typical trajectory of wastewater spikes leading to positive tests then hospital admissions.
2Variant landscape update
The dominant XFG variant has circulated for over a year, allowing population immunity to develop. Earlier concerns about the highly mutated BA.3.2 'Cicada' variant have subsided without significant spread. No new concerning variants have emerged yet, marking a departure from previous winters' variant-driven surges.
3Vaccination timing and coverage
This year's updated vaccines specifically target XFG variants, with both mRNA and protein options available. Experts recommend vaccination by mid-October, especially for high-risk groups. Health insurance should fully cover costs despite ongoing legal issues affecting federal vaccine recommendation committees.
4Pediatric vaccination challenges
Children under two face particular risks, with no prior immunity—Chin-Hong compares their vulnerability to 2020 levels. Half of children rely on the federal Vaccines for Children program, which is experiencing supply delays. Very young children require doctor visits for vaccination rather than pharmacy access.
5High-risk population priorities
Key vulnerable groups include those over 65, immunocompromised individuals, and pregnant people. Vaccination during pregnancy provides protection for newborns too young for immunization. Experts emphasize these groups should prioritize early vaccination given their elevated severe outcome risks.
6New prevention options
Xocova (ensitrelvir), a new 5-day oral regimen, can reduce post-exposure infection risk but isn't a vaccine substitute. Available by prescription with age restrictions (12+) and potential drug interactions. Paxlovid remains an option for infected individuals at risk of severe progression, working by inhibiting viral replication.
7Symptom patterns and long COVID
Current infections cause wide-ranging symptoms including fever, congestion, fatigue and GI issues, typically lasting up to a week. Long COVID continues to occur post-infection, though incidence rates remain difficult to quantify precisely. For most without underlying conditions, infections are more unpleasant than dangerous.
8Public health approach shift
With COVID now endemic, response focuses on targeted protection rather than population-wide restrictions. Wastewater surveillance provides early outbreak detection. The medical community emphasizes layered protection: vaccination, new antivirals, and awareness of high-risk periods as winter approaches.